Navigation Links
University of California, San Francisco (UCSF) Selects Conflict of Interest Management System
Date:9/11/2012

JERICHO, N.Y., Sept. 11, 2012 /PRNewswire/ -- Health Care Compliance Strategies, Inc. (HCCS) announced today that The University of California, San Francisco (UCSF) has selected the HCCS COI-SMART system to automate their conflict of interest disclosure process. The COI-SMART system will assist UCSF in complying with new National Institute of Health (NIH) conflict of interest disclosure regulations by managing and reporting on COI disclosures for nearly 5000 faculty, post-docs, and fellows.

(Logo: http://photos.prnewswire.com/prnh/20061010/NYTU194LOGO )

"We selected COI-SMART for its functionality, ease of use and scalability to meet the new NIH requirements for PHS grants and contracts," says Eric Mah, Senior Director, Research - UCSF. "With a large number of users involved in many research projects, it was imperative to have a flexible system that could be implemented quickly and would make the disclosure process straightforward and easy for our research investigators and administrators alike. HCCS' customer service and responsiveness is second to none."

COI-SMART provides full back-end management and reporting to eliminate paper-based conflict of interest disclosure management. Universities and other organizations see improved control and reduced risk. The system provides for the development of multi-level branching questionnaires, automated assignment of reviewers, the development of COI management plans, and data mining tools for auditing, tracking and reporting on potential conflicts of interest.

COI-SMART can be used for an annual COI survey process as well as for transactional or "elective" questionnaires. The system includes role-based tiered questions that allow respondents to provide detailed responses. Administrative dashboards provide a graphical representation of the status of the COI disclosure process.

"We're excited to bring COI-SMART to The University of California, San Francisco (UCSF)," says Ben Diamond, President of HCCS. "We are pleased that UCSF has determined that the unique features and user interface in COI-SMART will help to facilitate their process of disclosing, tracking, managing and reporting on potential conflicts of interest."

COI-SMART offers a Quick-Start Option to facilitate compliance for PHS funded research with the new NIH COI regulations.

About University of California, San Francisco (UCSF)
The University of California, San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. It is the only UC campus in the 10-campus system dedicated exclusively to the health sciences. 

About Health Care Compliance Strategies, Inc.  (HCCS)
HCCS is a leading provider of compliance training and tracking solutions.  HCCS has provided over 7 million hours of compliance and competency online training courses to Universities, research organizations, teaching facilities, hospitals, medical schools, health plans and other health care entities. HCCS provides expert training courses in Medicare, Medicaid, HIPAA, Harassment, Research, Patient Safety and more. COI-SMART is a solution for tracking and managing Conflicts of Interest disclosures.

For more information about COI-SMART, contact HCCS at (877) 933-4227, by email at info@hccs.com, or via the web at www.coismart.com or www.hccs.com.


'/>"/>
SOURCE Health Care Compliance Strategies
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. OncoSec Secures License for Electroporation Intellectual Property from University of South Florida
2. Islet Sciences Announces Exclusive License Agreement with Winthrop University Hospital to Commercialize a Beta Cell Loss Measurement Technology in Diabetes
3. First Evidence that Adipose Stem Cell-Based Critical Limb Ischemia Treatment is Safe & Effective is published in Circulation Journal by Lead Investigator Dr. Han Cheol Lee of Pusan National University
4. University of Miami study finds RBAC to possess promising immunomodulating effects with respect to natural killer cell and cytokine activity
5. Northwestern University Joins VIVO Network with Elseviers SciVal Experts
6. Chicago Celebrates First Informatics Week, Co-Chaired by Intelligent Medical Objects and Northwestern University
7. Worlds smallest semiconductor laser created by University of Texas scientists
8. Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
9. University of Utah physicists invent spintronic LED
10. University of Nottingham to play key role in European solar energy technology project
11. Western Carolina University, College of Business Appoints New Director of Entrepreneurship and Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  MDNA Life Sciences ... development of liquid biopsy tests based on the ... an exclusive license agreement with its first international ... liquid biopsy test for prostate cancer, the Prostate ... . This is the first overseas appointment ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
(Date:2/16/2017)...  Windtree Therapeutics, Inc. (Nasdaq: WINT ... KL4 surfactant therapies for respiratory diseases, announced today ... that aerosolized KL4 surfactant reduced lung inflammation and ... model. The Company believes that these preclinical data ... supports the role of KL4 surfactant as a ...
(Date:2/15/2017)... ... ... Park Systems , a leader in Atomic Force Microscopy (AFM) since ... productivity with single click reliable nanoscale images, is now available on Park XE series ... the image once done manually by the operator producing high quality nanoscale imaging in ...
Breaking Biology Technology:
(Date:1/30/2017)... 2017   Invitae Corporation (NYSE: ... companies, today announced that it will report its fourth ... guidance on Monday, February 13, 2017, and Invitae,s management ... 4:45 p.m. Eastern / 1:45 p.m. Pacific. ... review financial results, guidance, and recent developments and will ...
(Date:1/24/2017)... , Jan. 24, 2017  It sounds simple ... sock that monitors vital signs and alerts parents ... infant,s oxygen saturation level drops. But pediatric experts ... to parents, with no evidence of medical benefits, ... are marketed aggressively to parents of healthy babies, ...
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic (IVD) ... mergers and acquisitions (M&A), and Kalorama Information expects that ... acquisitions have been shifting. Generally, uncertainty in reimbursement and ... the U.S. has changed the acquisitions landscape. Instead of ... in companies buying partners outside of their home country ...
Breaking Biology News(10 mins):